Obsidian Therapeutics OBX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$701.2K (8 inflow days, 12 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 28.4% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 0.06% to 1.92% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| BlackRock | Mutual Fund | 2026/Q3 | +61,932 | 0.1% |
| Charles Schwab Investment Management | Mutual Fund | 2026/Q3 | +269,133 | 0.4% |
| Atlas Venture Advisors, Inc. | VC/PE Fund | 2026/Q3 | +4,503,149 | 7.3% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +2,441,332 | 4.0% |
| Alphabet Inc. | Public Company | 2026/Q3 | +1,224,869 | 2.0% |
| GV Management Company, LLC | VC/PE Fund | 2026/Q3 | +1,224,869 | 2.0% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +833,297 | 1.3% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +483,438 | 0.8% |
| Revelation Capital Management, LLC | VC/PE Fund | 2026/Q3 | +428,346 | 0.7% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +223,487 | 0.4% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +199,207 | 0.3% |
| TD Asset Management | Mutual Fund | 2026/Q3 | +140,520 | 0.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +61,732 | 0.1% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +635 | 0.0% |
| SBI Holdings, Inc. | Public Company | 2026/Q3 | +1 | 0.0% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 9 Nov 2026 | Mark L. Reisenauer | Other Derivative Acquisition | +75,364 | $13.74 | 75,364 | |
| 2 Aug 2026 | Julie Feder | Chief Financial Officer | Other Derivative Acquisition | +115,666 | $17.10 | 115,666 |
| 2 Aug 2026 | Parameswaran Hari | Chief Medical Officer | Other Derivative Acquisition | +232,450 | $17.10 | 232,450 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 1,184,895 | 1.9% | 3.9 |
| 15 Oct 2026 | 1,081,550 | 1.8% | 3.2 |
| 30 Sep 2026 | 884,528 | 1.4% | 1.0 |
| 15 Sep 2026 | 253,084 | 0.4% | 1.0 |
| 31 Aug 2026 | 81,457 | 0.1% | 1.0 |
| 14 Aug 2026 | 36,102 | 0.1% | 1.0 |
No comments yet — be the first to weigh in on OBX.
Sign in to join the discussion.